Voting Rights and Capital: Month End Disclosure

RNS Number : 8259A

Arix Bioscience Plc

03 January 2018

 

3 January 2018

Arix Bioscience plc

Voting Rights and Capital: Month End Disclosure

Pursuant to Disclosure and Transparency Rule 5.6.1:

As at 31 December 2017, the issued share capital of Arix Bioscience plc comprised 96,153,090 ordinary shares of £0.00001 each and 49,671 non-voting C Shares of £1.00 each. There were no shares held in treasury.

The total number of voting rights in Arix Bioscience plc was therefore 96,153,090.

The total voting rights figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Arix Bioscience plc under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

James Rawlingson                           Chief Financial Officer                [phone]

  - Ends -

 

END

 

 

MSCGCGDBSSGBGIX